Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Bio-Techne | TECH | 3. fév 2025 | 72.05 | -2.04 |
BioAffinity Technologies | BIAF | 3. fév 2025 | 0.71 | -6.54 |
BioAge Labs | BIOA | 3. fév 2025 | 4.71 | +2.61 |
BioAtla | BCAB | 3. fév 2025 | 0.45 | -3.38 |
BioCardia | BCDA | 3. fév 2025 | 2.41 | -2.43 |
Bioceres Crop Solutions | BIOX | 3. fév 2025 | 6.55 | -4.38 |
BioCryst Pharmaceuticals | BCRX | 3. fév 2025 | 7.62 | -3.54 |
Biodesix | BDSX | 3. fév 2025 | 1.01 | -1.94 |
Biodexa Pharma ADR | BDRX | 3. fév 2025 | 4.31 | -2.18 |
Biofrontera | BFRI | 3. fév 2025 | 1.12 | -0.89 |
Biogen | BIIB | 3. fév 2025 | 142.34 | -1.10 |
BioHarvest Sciences | BHST | 3. fév 2025 | 4.99 | 0.00 |
Biohaven | BHVN | 3. fév 2025 | 37.71 | -1.41 |
BioLife Solutions | BLFS | 3. fév 2025 | 26.62 | -2.51 |
BioLineRX ADR | BLRX | 3. fév 2025 | 3.39 | -4.78 |
BioMarin Pharmaceutical | BMRN | 3. fév 2025 | 62.44 | -1.45 |
Biomea Fusion | BMEA | 3. fév 2025 | 3.93 | -5.98 |
Biomerica | BMRA | 3. fév 2025 | 0.47 | -6.81 |
BiomX | PHGE | 3. fév 2025 | 0.73 | +0.84 |
Bionano Genomics | BNGO | 3. fév 2025 | 5.30 | +2.12 |
BioNexus Gene Lab | BGLC | 3. fév 2025 | 0.40 | -1.35 |
BioNTech ADR | BNTX | 3. fév 2025 | 119.82 | -3.19 |
BioRestorative Therapies | BRTX | 3. fév 2025 | 2.36 | -0.84 |
BioShares Biotechnology Clinical Trials Fund | BBC | 3. fév 2025 | 22.48 | -2.34 |
BioShares Biotechnology Products Fund | BBP | 3. fév 2025 | 61.45 | -1.42 |
biote | BTMD | 3. fév 2025 | 5.29 | +3.93 |
Bioventus A | BVS | 3. fév 2025 | 10.50 | -1.69 |
BioVie | BIVI | 3. fév 2025 | 1.60 | -3.03 |
BioXcel Therapeutics | BTAI | 3. fév 2025 | 0.31 | -5.61 |
BIP Bermuda Holdings | BIPI | 3. fév 2025 | 17.19 | -1.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.